中德临床肿瘤学杂志（英文版）2009，Vol.8Issue(9)：495-497,3.DOI:10.1007/s10330-009-0116-5
吉非替尼对晚期非小细胞肺癌患者生活质量的改善
Improvements of quality of life in patients with advanced non-small cell lung cancer treated with gefitinib
Yanmei Zou 1Hua Xiong 1Shiying Yu1
作者信息
- 1. Cancer Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
- 折叠
摘要
Abstract
e all more than 40%. QoL and symptom response correlated with disease control. The patients with better QoL had longer survival. Conclusion: gefitinib treatment can improve the QoL and symptoms of advanced NSCLC patients.关键词
non-small cell lung cancer (NSCLC)/quality of life (QoL)/gefitinibKey words
non-small cell lung cancer (NSCLC)/quality of life (QoL)/gefitinib引用本文复制引用
Yanmei Zou,Hua Xiong,Shiying Yu..吉非替尼对晚期非小细胞肺癌患者生活质量的改善[J].中德临床肿瘤学杂志（英文版）,2009,8(9):495-497,3.
